CERYOND



Trademark Coverage

No Class Specified

Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Owner

Eli Lilly and Company

Business in Indianapolis, IN

Owns 2497 trademarks

Timeline
  • Jan 13
    2014
    Abandonment Notice Mailed No Use Statement Filed
  • Jan 13
    2014
    Abandonment No Use Statement Filed
  • May 23
    2013
    Notice Of Approval Of Extension Request E Mailed
  • May 22
    2013
    Extension 1 Granted
  • Apr 24
    2013
    Extension 1 Filed
  • May 21
    2013
    Case Assigned To Intent To Use Paralegal
  • Apr 24
    2013
    TEAS Extension Received
  • Dec 11
    2012
    NOA E Mailed SOU Required From Applicant
  • Oct 16
    2012
    Official Gazette Publication Confirmation E Mailed
  • Oct 16
    2012
    Published For Opposition
  • Sep 26
    2012
    Notification Of Notice Of Publication E Mailed
  • Sep 13
    2012
    Law Office Publication Review Completed
  • Sep 11
    2012
    Assigned To LIE
  • Aug 30
    2012
    Approved For PUB Principal Register
  • Jul 06
    2012
    TEAS/Email Correspondence Entered
  • Jul 06
    2012
    Correspondence Received In Law Office
  • Jul 06
    2012
    TEAS Response To Office Action Received
  • Jan 08
    2012
    Notification Of Priority Action E Mailed
  • Jan 08
    2012
    Priority Action E Mailed
  • Jan 08
    2012
    Priority Action Written
  • Dec 13
    2011
    Assigned To Examiner
  • Oct 13
    2011
    New Application Office Supplied Data Entered In TRAM
  • Oct 10
    2011
    New Application Entered In TRAM